Plasmodium falciparum and TNF-α Differentially Regulate Inflammatory and Barrier Integrity Pathways in Human Brain

Marisol Zuniga1, Claudia Gomes1, Ze Chen1

  • 1Department of Microbiology, New York University School of Medicinegrid.201076.2, New York, New York, USA.

Mbio
|August 29, 2022
PubMed

Insights

Cerebral malaria disrupts the blood-brain barrier (BBB). Plasmodium falciparum-infected red blood cells severely increase BBB permeability, unlike TNF-α, suggesting parasite signaling as a therapeutic target for cerebral malaria.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Cell Biology

Background:

  • Cerebral malaria, a severe Plasmodium falciparum complication, involves blood-brain barrier (BBB) integrity loss, leading to brain swelling and mortality.
  • The roles of infected red blood cells and TNF-α in BBB disruption remain unclear.

Purpose of the Study:

  • To differentiate the effects of P. falciparum-infected red blood cells (iRBCs) and TNF-α on human brain microvascular endothelial cells (HBMECs) and BBB integrity.
  • To identify distinct signaling pathways triggered by these stimuli in brain endothelial cells.

Main Methods:

  • Utilized transcriptomic analysis and cellular assays on HBMEC lines and primary cells.
  • Assessed changes in barrier integrity, endothelial activation, and cell viability.

Main Results:

  • TNF-α induced significant endothelial activation but minimal HBMEC permeability increase.
  • P. falciparum iRBCs caused substantial HBMEC permeability increase without inducing cell death.
  • Transcriptomic profiles revealed parasite-specific endoplasmic reticulum stress response.

Conclusions:

  • P. falciparum iRBCs and TNF-α exert differential effects on brain endothelial cells.
  • Parasite-induced signaling, not TNF-α, is a primary driver of BBB disruption in cerebral malaria.
  • Parasite-induced pathways represent a potential therapeutic target for cerebral malaria.